SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-22-000005
Filing Date
2022-01-05
Accepted
2022-01-05 16:01:45
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164141648612518.html 4  
1 FORM 4 wf-form4_164141648612518.xml 4 6485
  Complete submission text file 0001599298-22-000005.txt   8062
Mailing Address C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE. SUNNYVALE CA 94085
Business Address
Clark Kenneth A (Reporting) CIK: 0001561736 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 22511040

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations